Summary

The global flow cytometry market is expected to reach USD 14.71 billion by 2032 from USD 6.40 billion in 2024, growing at a CAGR of 10.9% in the forecast period of 2025 to 2032.
Market Segmentation:
Global Flow Cytometry Market, By Product (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services, and Software), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End user (Pharmaceuticals and Biotechnology Companies, Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, CRO, Blood Bank, CMO & CDMO, Forensic Laboratories, and Others), Distribution Channel (Retail Sales and Direct Tenders), Country (U.S., Canada , Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, and Rest of Middle East & Africa) - Industry Trends & Forecast To 2032

Overview of Global Flow Cytometry Market Dynamics:

Driver
• Rising Prevalence of Chronic Diseases
Restrain

• High Cost of Flow Cytometry Instruments

Opportunity

• Increase in Adoption of Flow Cytometry Techniques in Research and Academia

Market Players:

The key market players operating in the Global Flow Cytometry market are listed below:

• BD
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Bennubio Inc.
• Enzo Biochem Inc.
• Apogee Flow Systems Ltd.
• Beckman Coulter, Inc.
• Coherent Corp.
• Cell Signaling Technology, Inc.
• Cytek Biosciences
• Biomérieux
• Cytonome/ST LLC

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 76
1.1 OBJECTIVES OF THE STUDY 76
1.2 MARKET DEFINITION 76
1.3 OVERVIEW OF THE GLOBAL FLOW CYTOMETRY MARKET 76
1.4 CURRENCY AND PRICING 78
1.5 LIMITATIONS 78
1.6 MARKETS COVERED 78
2 MARKET SEGMENTATION 81
2.1 MARKETS COVERED 81
2.2 GEOGRAPHICAL SCOPE 82
2.3 YEARS CONSIDERED FOR THE STUDY 83
2.4 DBMR TRIPOD DATA VALIDATION MODEL 84
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 87
2.6 MULTIVARIATE MODELLING 88
2.7 DBMR MARKET POSITION GRID 89
2.8 VENDOR SHARE ANALYSIS 90
2.9 SECONDARY SOURCES 91
2.10 ASSUMPTIONS 91
3 EXECUTIVE SUMMARY 92
4 PREMIUM INSIGHTS 97
4.1 PESTAL ANALYSIS 98
4.2 PORTERS FIVE FORCES ANALYSIS 99
5 GLOBAL FLOW CYTOMETRY MARKET: REGULATIONS 100
6 MARKET OVERVIEW 102
6.1 DRIVERS 104
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 104
6.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 105
6.1.3 GROWING USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 106
6.1.4 GROWING RESEARCH FUNDING 107
6.2 RESTRAINTS 108
6.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 108
6.2.2 LIMITATIONS OF FLOW CYTOMETRY 108
6.3 OPPORTUNITIES 110
6.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 110
6.3.2 RISING DEVELOPMENT OF PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 110
6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 111
6.4 CHALLENGES 112
6.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 112
6.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 112
7 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCT 114
7.1 OVERVIEW 115
7.2 REAGENTS AND CONSUMABLES 118
7.2.1 DYE 119
7.2.2 ANTIBODIES 119
7.2.3 BEADS 119
7.2.4 OTHERS 119
7.3 FLOW CYTOMETRY INSTRUMENTS 119
7.3.1 CELL ANALYZERS 121
7.3.1.1 CELL ANALYZERS, BY TYPE 121
7.3.1.1.1 IMAGING FLOW CYTOMETERS 121
7.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 121
7.3.1.2 CELL ANALYZERS, BY RANGE 122
7.3.1.2.1 HIGH-RANGE CELL ANALYZERS 122
7.3.1.2.2 MID-RANGE CELL ANALYZERS 122
7.3.1.2.3 LOW-RANGE CELL ANALYZERS 122
7.3.1.3 CELL ANALYZERS, BY MODALITY 122
7.3.1.3.1 BENCHTOP 123
7.3.1.3.2 STANDALONE 123
7.3.2 CELL SORTERS 123
7.3.2.1 BENCHTOP 123
7.3.2.2 STANDALONE 123
7.3.3 CELL SORTERS 123
7.3.3.1 HIGH-RANGE CELL ANALYZERS 124
7.3.3.2 MID-RANGE CELL ANALYZERS 124
7.3.3.3 LOW-RANGE CELL ANALYZERS 124
7.4 ACCESSORIES 125
7.4.1 FILTERS 126
7.4.2 DETECTORS 126
7.4.3 OTHERS 126
7.5 SERVICES 127
7.6 SOFTWARE 127
8 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY 128
8.1 OVERVIEW 129
8.2 CELL-BASED FLOW CYTOMETRY 132
8.2.1 FLOW CYTOMETRY INSTRUMENTS 133
8.2.2 REAGENTS & CONSUMABLES 133
8.2.3 ACCESSORIES 133
8.3 BEAD-BASED FLOW CYTOMETRY 133
8.3.1 FLOW CYTOMETRY INSTRUMENTS 133
8.3.2 REAGENTS & CONSUMABLES 133
8.3.3 ACCESSORIES 133
9 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATION 134
9.1 OVERVIEW 135
9.2 RESEARCH APPLICATIONS 138
9.2.1 CELL CYCLE ANALYSIS 139
9.2.2 CELL SORTING/SCREENING 139
9.2.3 CELL TRANSFECTION/VIABILITY 139
9.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 139
9.2.4.1 DRUG DISCOVERY 139
9.2.4.2 STEM CELL RESEARCH 139
9.2.4.3 IN VITRO TOXICITY TESTING 139
9.2.5 IMMUNOLOGY 140
9.2.6 APOPTOSIS 140
9.2.7 CELL COUNTING 140
9.2.8 OTHERS 140
9.3 CLINICAL APPLICATIONS 140
9.3.1 HAEMATOLOGY 141
9.3.2 CANCER 141
9.3.3 IMMUNODEFICIENCY DISEASES 141
9.3.4 ORGAN TRANSPLANTATION 141
9.3.5 OTHER CLINICAL APPLICATION 141
9.4 INDUSTRIAL APPLICATIONS 141
10 GLOBAL FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 142
10.1 OVERVIEW 143
10.2 RETAIL SALES 146
10.2.1 OFFLINE 146
10.2.2 ONLINE 146
10.3 DIRECT TENDERS 147
11 GLOBAL FLOW CYTOMETRY MARKET, BY END USER 148
11.1 OVERVIEW 149
11.2 PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES 152
11.3 ACADEMIC & RESEARCH INSTITUTES 153
11.4 HOSPITALS 153
11.5 CLINICAL TESTING LABORATORIES 154
11.6 CRO 154
11.7 BLOOD BANK 155
11.8 CMO & CDMO 155
11.9 FORENSIC LABORATORIES 156
11.10 OTHERS 156
12 GLOBAL FLOW CYTOMETRY MARKET, BY REGION 157
12.1 OVERVIEW 158
12.2 NORTH AMERICA 161
12.2.1 U.S. 170
12.2.2 CANADA 179
12.2.3 MEXICO 187
12.3 EUROPE 195
12.3.1 GERMANY 205
12.3.2 FRANCE 214
12.3.3 U.K 222
12.3.4 ITALY 230
12.3.5 SPAIN 238
12.3.6 RUSSIA 246
12.3.7 NETHERLANDS 254
12.3.8 SWITZERLAND 262
12.3.9 TURKEY 270
12.3.10 BELGIUM 278
12.3.11 AUSTRIA 286
12.3.12 IRELAND 294
12.3.13 NORWAY 302
12.3.14 POLAND 310
12.3.15 REST OF EUROPE 317
12.4 ASIA-PACIFIC 318
12.4.1 JAPAN 328
12.4.2 CHINA 337
12.4.3 INDIA 345
12.4.4 SOUTH KOREA 353
12.4.5 AUSTRALIA 362
12.4.6 SINGAPORE 370
12.4.7 THAILAND 378
12.4.8 MALAYSIA 386
12.4.9 INDONESIA 394
12.4.10 PHILIPPINES 402
12.4.11 REST OF ASIA-PACIFIC 411
12.5 SOUTH AMERICA 412
12.5.1 BRAZIL 421
12.5.2 ARGENTINA 429
12.5.3 PERU 437
12.5.4 REST OF SOUTH AMERICA 445
12.6 MIDDLE EAST AND AFRICA 446
12.6.1 SOUTH AFRICA 456
12.6.2 SAUDI ARABIA 465
12.6.3 U.A.E. 474
12.6.4 EGYPT 482
12.6.5 KUWAIT 490
12.6.6 ISRAEL 498
12.6.7 REST OF MIDDLE EAST AND AFRICA 506
13 GLOBAL FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 507
13.1 COMPANY SHARE ANALYSIS: GLOBAL 507
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 508
13.3 COMPANY SHARE ANALYSIS: EUROPE 509
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 510
14 SWOT ANALYSIS 511
15 COMPANY PROFILES 512
15.1 BD 512
15.1.1 COMPANY SNAPSHOT 512
15.1.2 REVENUE ANALYSIS 512
15.1.3 COMPANY SHARE ANALYSIS 513
15.1.4 PRODUCT PORTFOLIO 513
15.1.5 RECENT DEVELOPMENT 516
15.2 AGILENT TECHNOLOGIES, INC. 517
15.2.1 COMPANY SNAPSHOT 517
15.2.2 REVENUE ANALYSIS 517
15.2.3 COMPANY SHARE ANALYSIS 518
15.2.4 PRODUCT PORTFOLIO 518
15.2.5 RECENT DEVELOPMENT 520
15.3 THERMO FISHER SCIENTIFIC INC 521
15.3.1 COMPANY SNAPSHOT 521
15.3.2 REVENUE ANALYSIS 522
15.3.3 COMPANY SHARE ANALYSIS 522
15.3.4 PRODUCT PORTFOLIO 522
15.3.5 RECENT DEVELOPMENT 525
15.4 BIO-RAD LABORATORIES, INC. 526
15.4.1 COMPANY SNAPSHOT 526
15.4.2 REVENUE ANALYSIS 526
15.4.3 COMPANY SHARE ANALYSIS 527
15.4.4 PRODUCT PORTFOLIO 527
15.4.5 RECENT DEVELOPMENT 528
15.5 SARTORIUS AG 529
15.5.1 COMPANY SNAPSHOT 529
15.5.2 REVENUE ANALYSIS 530
15.5.3 COMPANY SHARE ANALYSIS 530
15.5.4 PRODUCT PORTFOLIO 530
15.5.5 RECENT DEVELOPMENT 532
15.6 APOGEE FLOW SYSTEMS LTD. 533
15.6.1 COMPANY SNAPSHOT 533
15.6.2 PRODUCT PORTFOLIO 533
15.6.3 RECENT DEVELOPMENT 533
15.7 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 534
15.7.1 COMPANY SNAPSHOT 534
15.7.2 REVENUE ANALYSIS 534
15.7.3 PRODUCT PORTFOLIO 535
15.7.4 RECENT DEVELOPMENT 536
15.8 BIOMÉRIEUX 538
15.8.1 COMPANY SNAPSHOT 538
15.8.2 REVENUE ANALYSIS 538
15.8.3 PRODUCT PORTFOLIO 539
15.8.4 RECENT DEVELOPMENT 539
15.9 BIOLEGEND, INC. 540
15.9.1 COMPANY SNAPSHOT 540
15.9.2 PRODUCT PORTFOLIO 540
15.9.3 RECENT DEVELOPMENT 540
15.10 BENNUBIO INC 541
15.10.1 COMPANY SNAPSHOT 541
15.10.2 PRODUCT PORTFOLIO 541
15.10.3 RECENT DEVELOPMENT 541
15.11 COHERENT CORP. 542
15.11.1 COMPANY SNAPSHOT 542
15.11.2 REVENUE ANALYSIS 542
15.11.3 PRODUCT PORTFOLIO 543
15.11.4 RECENT DEVELOPMENT 543
15.12 CYTONOME/ST, LLC 544
15.12.1 COMPANY SNAPSHOT 544
15.12.2 PRODUCT PORTFOLIO 544
15.12.3 RECENT DEVELOPMENTS 545
15.13 CYTOBUOY 546
15.13.1 COMPANY SNAPSHOT 546
15.13.2 PRODUCT PORTFOLIO 546
15.13.3 RECENT DEVELOPMENT 547
15.14 CELL SIGNALING TECHNOLOGY, INC 548
15.14.1 COMPANY SNAPSHOT 548
15.14.2 PRODUCT PORTFOLIO 548
15.14.3 RECENT DEVELOPMENT 549
15.15 CYTEK BIOSCIENCES 550
15.15.1 COMPANY SNAPSHOT 550
15.15.2 PRODUCT PORTFOLIO 550
15.15.3 RECENT DEVELOPMENT 551
15.16 DIASORIN S.P.A. 552
15.16.1 COMPANY SNAPSHOT 552
15.16.2 REVENUE ANALYSIS 552
15.16.3 PRODUCT PORTFOLIO 553
15.16.4 RECENT DEVELOPMENT 553
15.17 ELABSCIENCE BIONOVATION INC. 554
15.17.1 COMPANY SNAPSHOT 554
15.17.2 PRODUCT PORTFOLIO 554
15.17.3 RECENT DEVELOPMENT 555
15.18 ENZO BIOCHEM, INC 556
15.18.1 COMPANY SNAPSHOT 556
15.18.2 REVENUE ANALYSIS 556
15.18.3 PRODUCT PORTFOLIO 557
15.18.4 RECENT DEVELOPMENT 558
15.19 MILTENYI BIOTEC AND/OR ITS AFFILIATES 559
15.19.1 COMPANY SNAPSHOT 559
15.19.2 PRODUCT PORTFOLIO 559
15.19.3 RECENT DEVELOPMENT 561
15.20 MERCK KGAA 562
15.20.1 COMPANY SNAPSHOT 562
15.20.2 REVENUE ANALYSIS 562
15.20.3 PRODUCT PORTFOLIO 563
15.20.4 RECENT DEVELOPMENT 564
15.21 NANOCELLECT BIOMEDICAL 565
15.21.1 COMPANY SNAPSHOT 565
15.21.2 PRODUCT PORTFOLIO 565
15.21.3 RECENT DEVELOPMENTS 566
15.22 NEOGENOMICS LABORATORIES 568
15.22.1 COMPANY SNAPSHOT 568
15.22.2 REVENUE ANALYSIS 569
15.22.3 PRODUCT PORTFOLIO 569
15.22.4 RECENT DEVELOPMENT 569
15.23 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 570
15.23.1 COMPANY SNAPSHOT 570
15.23.2 PRODUCT PORTFOLIO 570
15.23.3 RECENT DEVELOPMENTS 571
15.24 ORLFO TECHNOLOGIES 572
15.24.1 COMPANY SNAPSHOT 572
15.24.2 PRODUCT PORTFOLIO 572
15.24.3 RECENT DEVELOPMENT 572
15.25 STRATEDIGM, INC 573
15.25.1 COMPANY SNAPSHOT 573
15.25.2 PRODUCT PORTFOLIO 573
15.25.3 RECENT DEVELOPMENTS 574
15.26 SONY BIOTECHNOLOGY INC 575
15.26.1 COMPANY SNAPSHOT 575
15.26.2 PRODUCT PORTFOLIO 575
15.26.3 RECENT DEVELOPMENT 577
15.27 SYSMEX ASIA PACIFIC PTE LTD (PART OF SYSMEX CORPORATION) 578
15.27.1 COMPANY SNAPSHOT 578
15.27.2 REVENUE ANALYSIS 578
15.27.3 PRODUCT PORTFOLIO 579
15.27.4 RECENT DEVELOPMENT 580
15.28 TAKARA BIO INC. 581
15.28.1 COMPANY SNAPSHOT 581
15.28.2 PRODUCT PORTFOLIO 581
15.28.3 RECENT DEVELOPMENT 582
15.29 UNION BIOMETRICA, INC. 583
15.29.1 COMPANY SNAPSHOT 583
15.29.2 PRODUCT PORTFOLIO 583
15.29.3 RECENT DEVELOPMENTS 584
16 QUESTIONNAIRE 586
17 RELATED REPORTS 589